The October issue of Pharmafocus is now live!

pharmafile | September 29, 2016 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Pharmafocus, Pharmafocus new issue 

The latest edition of Pharmafocus is available online now. In this issue, we examine the key issue of medical education in the industry and also place NICE and the newly-reformed CDF under a harsh lens; are they still fit for purpose to allow UK drugs to access the market?

Mylan has caused outrage in the industry over the past month for its 500% increase of its flagship EpiPen epinephrine auto-injector. The ensuing story has seen the company embroiled in a series of financial investigations and even CEO Heather Bresch appearing before US lawmakers to defend the decision. Our front page brings you the full story.

And in our special in-depth feature on the US election, we take a look at how the two presidential candidates stack up on key issues to the pharma industry including regulatory procedures and the ongoing price-hike scandal.

Advertisement

Related Content

Rare disease clinical trials: the urgent need for patients to be heard

Ahead of Clinical Trials Day, Soraya Bekkali, from Alexion, AstraZeneca Rare Disease, highlights the urgent …

Sustainability in pharma

Betsy Goodfellow from Pharmafocus considers the need for sustainable practices in the pharma industry and assesses various …

pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

The Gateway to Local Adoption Series

Latest content